BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37465622)

  • 1. Predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide level for atrial fibrillation recurrence after radiofrequency catheter ablation.
    Zhao Q; Yang W; Li X; Yao M; Guo J; Wang Y; Shan Z
    Postepy Kardiol Interwencyjnej; 2023 Jun; 19(2):163-170. PubMed ID: 37465622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
    Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
    J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.
    Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS
    Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
    Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
    Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults.
    Tang Q; Guo XG; Sun Q; Ma J
    BMC Cardiovasc Disord; 2022 May; 22(1):219. PubMed ID: 35568806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
    Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
    Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation.
    Barmano N; Charitakis E; Kronstrand R; Walfridsson U; Karlsson JE; Walfridsson H; Nystrom FH
    PLoS One; 2019; 14(4):e0215121. PubMed ID: 30970005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
    Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum relaxin level predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
    Qu X; Chen L; Sun L; Chen C; Gao Z; Huang W; Zhou H
    Heart Vessels; 2019 Sep; 34(9):1543-1551. PubMed ID: 30937522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
    Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
    PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of serum adiponectin on progression of atrial fibrillation.
    Yamaguchi N; Okumura Y; Watanabe I; Nagashima K; Takahashi K; Iso K; Watanabe R; Arai M; Kurokawa S; Ohkubo K; Nakai T; Hirayama A
    J Arrhythm; 2017 Dec; 33(6):608-612. PubMed ID: 29255509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Predictors of Late Recurrence in Young Patients with Atrial Fibrillation after Catheter Ablation.
    Xu H; Chen X; Zhang Y; Zhu K; Zhao J; Qin F; Tao H
    Comput Math Methods Med; 2023; 2023():7892185. PubMed ID: 37284170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
    Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
    ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation.
    Wei Y; Liu S; Yu H; Zhang Y; Gao W; Cui M; Li L
    Mediators Inflamm; 2020; 2020():8360936. PubMed ID: 32904560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of N-terminal pro-B-type natriuretic peptide measurement in the follow up of pulmonary vein ablation].
    Arana-Rueda E; Pedrote A; García-Riesco L; Arce-León Á; Guerrero-Márquez F; Rodríguez-Rodríguez J
    Med Clin (Barc); 2015 Sep; 145(6):248-50. PubMed ID: 25561181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
    Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.